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Abstract 
The experiment involves analysis of nine brands of hyoscine butylbromide using ultra violet spectrophotometer 
in the range of (200-400nm) and high performance liquid chromatography (HPLC) in which the samples were 
dissolved in various solvents and their various absorbance, peak area at various wavelength were determined and 
compared with that of the standard, wavelength of maximum absorbance at 210nm for hyoscine butylbromide. 
Percentage and milligramme content for each sample was determined so as to note if it was within the acceptable 
range of (92.5-107.5%) for hyoscine butylbromide. For those that passed the test or if it was below or above the 
range for samples that are substandard or highly concentrated. 
The samples absorbance and peak area was used along side with the standard absorbance and peak area to 
calculate the percentage content of each sample. 
It was observed that of the  
Of the nine samples of hyoscine butylbromide tablet, only shreecopan with 93.6% passed using UV 
spectrophotometer while bixkopan with 99.8%, buscomac 101.6%, spanil 97.2% and unipan 104.7% passed 
using HPLC. 
KEYWORDS: Hyoscine Butylbromide, UV, HPLC 
 
1. Introduction 
Giving the authorization of the flow of different generic drug products by the government into the 
market has made it paramount for the government to make sure that these drugs have the required specifications 
at all time. Recent reports indicate the availability of substandard and counterfeit drugs has reached a disturbing 
proportion in many low-income countries. (http://www.usp.org/azindex) 
The introduction of generic drug products from multiple sources into health care delivery system of 
developing countries was aimed at improving the overall health care delivery system in such countries. However, 
this has been accompanied by a variety of problems of which the most critical is the widespread distribution of 
fake and substandard drug products. (Adebolagun et al, 2007). 
Butylscopolamine is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, 
or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not an 
analgesic in the normal sense, since it doesn't 'mask' or 'cover over' the pain, but rather works to prevent painful 
cramps and spasms from occurring in the first place. The attachment of the butyl-bromide moiety effectively 
prevents the movement of this drug across the blood–brain barrier, effectively minimizing undesirable CNS side-
effects associated with scopolamine/hyoscine (Tripathi, 2003). 
 
1.1 Buscopan 
One of the earliest alkaloids to be isolated from plant sources is Scopolamine, which has been in use since it was 
isolated by the German scientist Albert Ladenburg in 1880. The use of various preparations from its plant-based 
form is learnt from the healing arts of some of the world’s oldest cultures and perhaps even pre-historic times. In 
India Ancient Hindu physicians knew of the antispasmodic effects of a relative of the Duboisia shrub. In the 
search for a safe and effective treatment for abdominal pain and cramp, scientists based at Ingelheim prepared a 
semisynthetic derivative from the extract of elite Duboisia plants grown in greenhouses. This molecule, 
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.4, No.23, 2014 
 
187 
 
Butylscopolamine, was free of the undesirable side-effects on the central nervous system, typical of 
Scopolamine, and the medication, on sale since 1952, was immediately recognized as a safe and effective 
antispasmodic. Today, Butylscopolamine, also known as Scopolamine butylbromide, butylhyoscine or hyoscine 
butylbromide, is the world’s leading and most trusted treatment for pain and discomfort caused by muscle 
spasms and cramps. It cannot be considered an analgesic in the normal sense, in that it does not ‘mask’ or 
‘cover’ the pain, but rather works to prevent the pain from occurring in the first place (Pharmacotherapy Update, 
2009). 
  
1.2 Chemical Structure:                    
 
(British pharmacopoeia, 2006)  (BP 2008). 
1.3 IUPAC name:(1S,3s,5R,6R,7S,8r)-6,7-epoxy-8-butyl-3-[(S)-tropoyloxy]tropanium bromide. 
Empirical formula:   C21H30BrNO4 
Molecular weight:  440.4 
Solubility:  freely soluble in water and in methylene chloride, sparingly soluble in anhydrous methanol. 
Protein binding: Low 
Half-life:  5 hours 
Excretion: Renal (50%) and fecal 
Description: a white or almost white, crystalline powder, odourless, or almost odourless. 
( Indian pharmacopoeia 2007) 
 
 
 2. Materials  and Method 
2.1 Materials 
 Different brands of hyoscine butyl bromide were used for the study 
Pure sample of the drugs were obtained from NAFDAC which served as standard 
Writing and labeling materials,  
Measuring cylinder, Beakers, 1000ml volumetric flask, 100ml volumetric flask, 50ml volumetric flask, 
Sonicator, Filter paper, Spatula, High performance liquid chromatography set up, UV Visible spectrophotometer 
(Beckman), Analytical weighing balance, Pestle and mortar, Distilled water, All reagents used were obtained 
from NAFDAC office, Maiduguri. Sani et. al (2012)a 
2.2 Practical Method 
The methods employed for the purpose of this study are the UV visible spectrophotometric and high 
performance liquid chromatographic methods Sani et. al (2012)b 
2.3 Practical Procedure 
The tablets were assayed spectrophotometrically using the following procedures 
2.4 UV Procedure for Hyoscine Butyl Bromide 
- The average weight of the tablets from each sample was determined by weighing ten(10) tablets and dividing the 
results gotten by ten to obtain the average weight 
- From the value gotten the equivalent weight of 10mg of each brand was weighed accurately and transferred into 
25ml volumetric flasks. All the nine samples were labelled using pen and masking tape. 
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- To each volumetric flask, 15ml of 0.001M HCl was poured and sonicated for few minutes to dissolve the drug 
molecule and made up to 25ml with the same solvent 
-  The mixture in each flask was mixed well and filtered through a filter paper into clean beakers. 
- The UV spectrophotometer was put at zero by running a base line using 0.001M HCl solution as blank. 
- The absorbance of each sample was determined at the wavelength of 210nm by putting small amount of the 
sample into a cuvette, and the cuvette was put back into the machine. 
- The same procedure was repeated for the standard using 10mg of the powdered standard and the absorbance 
determined and from which the % content and mg content was determined as  
% content = Absorbance of sample x 100 
               Absorbance of standard 
Mg content = % content x  Manufactures claim  Sani et al (2012)c 
   100 
2.5 HPLC Procedure for Hyoscine Butyl Bromide 
- The average weight of the tablets from each sample was determined by weighing ten(10) tablets and dividing the 
results gotten by ten to obtain the average weight 
- From the value gotten the equivalent weight of each brand was weighed accurately and transferred into 25ml 
volumetric flasks. All the ten samples were labelled using pen and masking tape. 
- To each volumetric flask, 15ml of 0.001M HCl was poured and sonicated for few minutes to dissolve the drug 
molecule and made up to 25ml with the same solvent 
-  The mixture in each flask was mixed well and filtered through a filter paper into clean beakers. The prepared 
samples were poured into the vials before injecting into the HPLC machine and the readings taken. 
- The same procedure was repeated for the standard using 10mg of the powdered standard and the peak area 
determined and from which the % content and mg content was determined. 
 Chromatographic procedure was carried out using 
a) A stainless steel column (25cm-4.6mm) packed with octadecylsilyl silica gel for chromatography(10µ) 
(lichrosorb 10µ c8  column is suitable) 
b) A solution of 2.0 of sodium dodecyl sulphate in a mixture of 370 of 0.001MHCL and 680ml of methanol as the 
mobile phase with a flow rate of 2ml/minute. 
c) A detection wavelength of 210nm. Sani et. al (2012)d 
 
3. Result 
The data below shows the result of UV spectrophotometer which is used to calculate the percentage content and 
milligram content of the drugs. The results are shown below.  
3.1 UV-Spectrophotometry for Hyoscine Butyl Bromide 
Percentage and milligram content of different brands of Hyoscine Butyl Bromide using UV – Spectrophotometry  
Unipan  
% content = 39.110 x 100 = 70.38% 
           55.568 
mg content = 70.38  x 10 = 7.04mg 
         100 
 
HBBR 
%content = 29.933 x 100 = 54% 
      55.568 
mg content = 54  x 10 = 5.4mg 
       100 
Buscopan 
%content = 82.607 x 100 = 149% 
      55.568 
mg content = 149  x 10 = 14.9mg 
         100 
 
Buscomac 
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%content = 45.700 x 100 = 82.24% 
       55.568 
mg content = 82.24  x 10 = 8.2mg 
         100 
 
Spanil 
%content = 47.626 x 100 = 85.7% 
       55.568 
mg content = 85.7  x 10 =  8.6mg 
         100 
 
Shreecopan 
%content = 53.019 x 100 = 93.61% 
       55.568 
mg content = 93.61  x 10 = 9.4mg 
          100 
 
Bixkopan 
%content = 28.813 x 100 = 51.9% 
      55.568 
mg content = 51.9 x 10 = 5.2mg 
         100 
 
Boxcotab 
%content = 48.634 x 100 = 88% 
       55.568 
mg content = 88  x 10 = 8.8mg 
       100 
 
Cinex 
%content = 50.434 x 100 = 90.8% 
     55.568 
mg content = 90.8  x 10 = 9.1mg 
       100 
 
Table 1 UV absorbance of Hyoscine Butyl Bromide at a wavelength of 210 (E1%) 
Sample                                                                                               Absorbance (A) 
Unipan                                                                                                    39.110 
HBBR                                                                                                       29.933 
Buscopan                                                                                                82.607 
Buscomax                                                                                                45.700 
Spanil                                                                                                       47.626 
Shreecopan                                                                                             52.019 
Bixkopan                                                                                                  28.813 
Boxcotab                                                                                                  48.634 
Cinex                                                                                                         50.434 
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Table 2 Percentage content and milligramme content of different brands of Hyoscine Butyl Bromide using UV 
Sample                                    %content                                                     Mg content 
Unipan                                         70.38                                                               7.04 
HBBR                                             54                                                                    5.4 
Buscopan                                     149                                                                 14.9 
Buscomac                                      82.24                                                            8.2 
Spanil                                               85.7                                                            8.6 
Shreecopan                                    93.61                                                          9.4 
Bixcopan                                         51.9                                                             5.2 
Boxcotab                                          88                                                               8.8 
Cinex                                               90.8                                                              9.1 
 
3.2 HPLC Result 
The calculation below shows the result gotten from the HPLC method in analysis 
% content =   Peak area of sample    x   100 
     Peak area of standard 
 
mg content  =  % content  x   Standard claim 
  100 
 
Figure:1 
Analyst:  manager  
Sample ID:  COLOSPAN 070513 secondary standard  Vial:  190   Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.023 9874861 100.000 MM 
     
Totals     
  9874861 100.000  
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Figure:2 
Analyst:  manager  
Sample ID:  BIXKOPAN 070513    Vial:  120    Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.020 9859493 100.000 MM 
     
Totals     
  9859493 100.000  
 
 
% content = 9859493 x 100 = 99.8% 
           9874861 
 
 
Mg content = 99.8 x 10 = 9.98mg 
        100 
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Figure:3 
Analyst:  manager  
Sample ID:  BOXCOTAB 070513   Vial:  110    Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.027 8595099 100.000 MM 
     
Totals     
  8595099 100.000  
 
 
% content = 8595099 x 100 = 87.0% 
       9874861 
 
 
Mg content = 87.0 x 10 = 8.7mg 
         100 
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Figure:4 
Analyst:  manager  
Sample ID:  BUSCOMAC 070513   Vial:  200    Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  0.837 1003551 99.990 MM 
  9.940 98 0.010 BE 
     
Totals     
  1003649 100.000  
 
 
% content = 1003551 x 100 = 101.6% 
      9874861 
 
Mg content = 101.6 x 10 = 10.2mg 
          100 
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Figure:5 
Analyst:  manager  
Sample ID:  BUSCOPAN 070513   Vial:  170    Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.023 8413441 100.000 MM 
     
Totals     
  8413441 100.000  
 
% content = 8413441 x 100 = 85.2% 
        9874861 
 
Mg content = 85.2 x 10 = 8.5mg 
         100 
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Figure:6 
Analyst:  manager  
Sample ID:  HBBR 070513    Vial:  140   Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  0.040 513 0.007 BI 
  1.030 7175815 99.993 MM 
     
Totals     
  7176328 100.000  
 
% content = 7175815 x 100 = 72.7% 
      9874861 
 
Mg content = 72.7 x 10 = 7.3mg 
        100 
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Figure:7 
Analyst:  manager  
Sample ID:  SPANIL 070513    Vial:  150   Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.020 9595509 100.000 MM 
     
Totals     
  9595509 100.000  
 
 
% content = 9595509 x 100 = 97.2% 
      9874861 
 
Mg content = 97.2 x 10 = 9.7mg 
        100 
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Figure:8 
Analyst:  manager  
Sample ID:  SHREEPOPAN 070513    Vial:  130  Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.020 9042098 100.000 MM 
     
Totals     
  9042098 100.000  
 
% content = 9042098 x 100 = 91.6% 
      98744861 
 
Mg content = 91.6 x 10 = 9.2mg 
        100 
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Figure:9 
Analyst:  manager  
Sample ID:  UNIPAN 070513   Vial:  160  Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.020 10337846 100.000 MM 
     
Totals     
  10337846 100.000  
 
% content = 10337846 x 100 = 104.7% 
       98744861 
 
Mg content = 104.7 x 10 = 10.5mg 
         100 
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Figure:10 
Analyst:  manager  
Sample ID:  CINEX 070513    Vial:  180    Injection Volume:  20  
Minutes
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UV-VIS Results     
Name Retention Time Area Area Percent Integration Codes 
  1.027 12365948 100.000 MM 
     
Totals     
  12365948 100.000  
 
% content = 12365948 x 100 = 125.2% 
       9874861 
 
Mg content = 125.2 x 10 = 12.5mg 
          100 
 
Table 3 Percentage and milligramme content of different brands of Hyoscine Butyl Bromide using 
HPLC 
Sample                                    % content                                                     mg content 
Unipan                                      104.7                                                                10.5 
HBBR                                         72.7                                                                  7.3 
Buscopan                                  85.2                                                                 8.5 
Buscomax                                 101.6                                                               10.2 
Spanil                                         97.2                                                                 9.7 
Shreecopan                               91.6                                                                9.2 
Bixkopan                                    99.8                                                                10 
Boxcotab                                    87.0                                                               8.7 
Cinex                                          125.2                                                              12.5 
 
4. Discussion 
 As stated by the British Pharmacopoeia, a hyoscine butylbromide should contain not less than 92.5% 
and not more than 107.5% of the stated amount of hyoscine butyl bromide. (BP 2008) 
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A standard hyoscine butyl bromide tablet using a secondary standard has an absorbance of 55.568 at a 
wavelength of 210nm. 
From the result obtained using UV visible spectrophotometer shreecopan with percentage content of 93.6% fell 
within the range specified by the BP while unipan with percentage content of 70.38%, hyoscine butyl bromide 
54%, buscopan 149%, buscomac 82.24%, spanil 85.7%, bixkopan 51.9%, boxcotab 88%, cinex 90.8% fell either 
above or below the range set by the BP and are said to have failed the test. 
In the high performance liquid chromatography (HPLC) analysis carried out on the same sample using the same 
limit set by BP, 
 For hyoscine butylbromide tablet, bixkopan with percentage content of 99.8%, buscomac 101.6%, 
spanil 97.2% and unipan 104.7% are said to have passed the test because they are within the set limit while 
Boxcotab 87.0%, Buscopan 85.2%, Hyoscine butyl bromide bromide 72.7%, Shreecopan 91.6% and Cinex 
125.2% are said to have failed the test because they were either below or above the set limit of the BP. 
 
5. CONCLUSION 
 Following the BP specification, it can be concluded that For hyoscine butyl bromide using UV only 
shreecopan passed the test while unipan, hyoscine butyl bromide, buscomac, spanil, bixkopan, boxcotab and 
cinex failed the test but for HPLC Bixkopan, buscomac, spanil and unipan passed the test while Boxcotab, 
Buscopan, hyoscine butyl bromide, Shreecopan and Cinex failed the test.  
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